Catriona Yale
2021
In 2021, Catriona Yale earned a total compensation of $1.8M as Chief Development Officer at Akero Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $160,684 |
---|---|
Option Awards | $1,190,645 |
Salary | $401,709 |
Total | $1,753,038 |
Yale received $1.2M in option awards, accounting for 68% of the total pay in 2021.
Yale also received $160.7K in non-equity incentive plan and $401.7K in salary.
Rankings
In 2021, Catriona Yale's compensation ranked 6,575th out of 12,406 executives tracked by ExecPay. In other words, Yale earned more than 47.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,575 | 47th |
Manufacturing | 2,833 | 48th |
Chemicals And Allied Products | 1,247 | 47th |
Drugs | 1,112 | 47th |
Pharmaceutical Preparations | 805 | 48th |
Yale's colleagues
We found four more compensation records of executives who worked with Catriona Yale at Akero Therapeutics in 2021.